Tags

CAIRS

The patient's uncorrected distance visual acuity (UDVA) values were 0.2 decimal in his right eye (OD) and 0.08 in the left (OS) His corrected distance visual Acuity (CDVA) was  +0.5 -8.0 77° = 0.63 OD and +2.0 -10.0 108° =0.25 OS. At 1-day postoperatively, the UDVA already improved to 0

In clinical report, Jul 11, 2024

Harold Ridley's birthday, 10 July

2024 marks the 75th anniversary of the first intraocular lens manufactured by Rayner in 1949. Sir Harold Ridley was born in Kibworth, a village in Leicestershire in the English Midlands, on 10th July 1906. He was the elder son of Nicholas Charles Ridley and Margaret (née Parker)

In lab history, Jul 10, 2024

EndoArt® : 5 years

Five years ago, I performed the first human implantation of the **EndoArt®** artificial DMEK-Implant at our Heidelberg University Eye Clinic. Based on a recent examination, I am pleased to say that the patient and the Implant are doing fine five years on.

In lab research, clinical research, Jun 18, 2024

Predicting emulsification in Silicone Oil

Researchers studied straylight in explanted silicone oil samples to predict emulsification, finding increased straylight in samples from patients with visible oil droplets and specific indications, suggesting it as an early indicator for timely silicone oil removal.

In lab research, May 28, 2024

A rare case of Calcification

A rare case of intraocular lens (IOL) calcification in a patient with Ehlers-Danlos syndrome was studied, highlighting the importance of considering patient host factors in IOL selection.

In lab research, May 27, 2024

New IOL material - xPIB

Researchers have developed a novel intraocular lens (IOL) made of crosslinked polyisobutylene (xPIB), which showed promising results in terms of material quality and optical performance. The Eyedeal lens demonstrated lower glistening density and a higher contact angle compared to the AcrySof lens, a widely used control. The study suggests that xPIB could be a suitable material for IOLs, with clinical trials already underway in China and planned for Europe.

In Lab research, Mar 11, 2024

Oil and Lenses don't mix

Researchers studied how silicone oil adhesion to intraocular lenses (IOLs) affects straylight, finding significant increases in straylight. The study also showed that the cleaning solution F4H5 can reverse straylight values, but surface changes remain.

In Lab news, Silicone oIl study, Nov 26, 2023

The safety of Reversible Trifocality.

The paper "Rotational Stability of Toric Capsular Bag–Fixated Intraocular Lenses in Duet Procedure for Reversible Trifocality" evaluates the long-term rotational stability of toric intraocular lenses in polypseudophakic eyes. The study found that the presence of a second lens in the sulcus did not affect the rotational stability of the first lens in the capsular bag.

In clinical news, Oct 14, 2023

DOG 2023 -Group Photo

The annual congress of the German Society of Ophthalmology (D.O.G.) took place on September 29, 2023, in Berlin, featuring a group photo of ophthalmologists from hospitals, medical centers, and research centers, including the David J Apple Center for Vision Research.

In lab news, Sep 29, 2023

Comparing Multisert and AutonoMe.

Comparing Multisert and AutonoMe IOL injectors, a study found both allowed safe implantation, but Multisert showed more consistent behavior and less injector damage.

In lab, news, Sep 26, 2023

APACRS LIM Lecture

Prof. Gerd U. Auffarth delivered the 2023 APACRS LIM Lecture, discussing current and future developments in intraocular implants with new materials at the 35th APACRS Annual Meeting in Singapore.

In lab news, Aug 12, 2023

Overcoming implantation challenges with SING IMT

The SING IMT is a second-generation implantable miniature telescope designed to improve visual acuity and quality of life in patients with late-stage age-related macular degeneration (AMD). It features a smaller incision and improved surgical techniques compared to its predecessor. The device has shown significant improvements in distance and near visual acuity and is considered safe and effective in short-term studies.

In news, Aug 01, 2023

Enlarged incisions – but why?

Researchers analyzed 409 incisions from 13 IOL injector models to identify factors affecting final incision size in cataract surgery, finding that injector tip diameter, preoperative incision size, insertion depth, and incision length significantly impact final incision size.

In lab news, Jun 29, 2023

DOC23 Success

The David J Apple Laboratory celebrates success at the 35th International Congress of German Ophthalmic Surgery (DOC) in Nuremberg, where research fellows Leonie Britz and Max Hammer won "Best Paper of Session" Awards for their lectures.

In lab news, Jun 20, 2023

Introducing Dynamic Stimulation Aberrometry

Researchers introduced dynamic stimulation aberrometry (DSA) to objectively measure binocular accommodation in 91 patients, finding that accommodative amplitude decreases with age and that DSA records pupil motility dynamically.

In lab, news, , Apr 29, 2023

Two Apple cores

Dr. David J. Apple, a renowned ophthalmologist and pathologist, founded the David J. Apple Laboratory for Ophthalmic Devices Research. He trained over 200 students and doctors, known as the "Apple Korps," and made significant contributions to cataract surgery and intraocular lens (IOL) implantation. After his death in 2011, his laboratory was transferred to the University of Heidelberg, Germany, where Dr. Gerd U. Auffarth continues his work, now known as the Auffarth-Apple Korps.

In news, history, Mar 01, 2023

We're Recruiting!

The David J Apple Center for Vision Research is recruiting a student researcher to work on new projects involving material science applications for posterior segment ocular disease. The position involves laboratory bench research, rheological analyses, and Wet Lab surgery projects, with the possibility to conduct a medical doctoral thesis.

In lab, news, Jan 23, 2023

Merci beaucoup Philippe

Professor Philippe Sourdille delivered the 1st David J. Apple MD Memorial Lecture, "Events I Have Witnessed Over Many Years," at the University-Eye-Clinic in Heidelberg, Germany, sharing a fascinating journey through decades of ophthalmic research and technology.

In lab, news, Jul 18, 2022

Why Heidelberg?

Heidelberg University is a public research university in Germany, founded in 1386. It is known for its strong research tradition, with 55 Nobel Prize winners affiliated with the university. The university has two main campuses, one in the Old Town and another in Neuenheimer Feld, which houses the medical and natural sciences faculties. Heidelberg is consistently ranked among Europe's top universities, with a strong focus on international education and research collaborations.

In history, lab, Oct 24, 2012

sticky

EndoArt® : 5 years

Five years ago, I performed the first human implantation of the **EndoArt®** artificial DMEK-Implant at our Heidelberg University Eye Clinic. Based on a recent examination, I am pleased to say that the patient and the Implant are doing fine five years on.

In lab research, clinical research, Jun 18, 2024

Welcome

The David J Apple Laboratory continues the pioneering work of Dr. David Apple which focuses on intraocular lens research and improving cataract surgery techniques.

In lab, Jan 07, 2013

feature

Team VitreoSub is a winner!

The provided sources discuss various topics related to the vitreous body and retinal care. The vitreous body is a gel-like substance that fills the posterior chamber of the eye, maintaining the eyeball's shape. Vitreous Retina Macula Consultants of New York (VRMNY) is involved in clinical trials for wet age-related macular degeneration and diabetic macular edema, and their doctors have spoken at conferences on multimodal imaging and ophthalmic ultrasonography. Healio provides news articles, videos, and podcasts on retinal conditions, including the use of multimodal imaging, novel VEGF inhibitors, and mitochondrial stabilizers. Vitreoretinal Consultants of NY shares updates on their practice and announces the win of the Science4Life Venture Cup 2024 by their team, VitreoSub, for developing vitreous body replacement strategies.

In lab news, Dec 13, 2023